B-RAF MUTATION-RELATED TUMORS

Clinical trials for B-RAF MUTATION-RELATED TUMORS explained in plain language.

Never miss a new study

Get alerted when new B-RAF MUTATION-RELATED TUMORS trials appear

Sign up with your email to follow new studies for B-RAF MUTATION-RELATED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

First human test of new cancer drug halted early

Disease control Terminated

This early-stage study aimed to test the safety and find the right dose of an experimental drug called BGB-3245 in people with advanced solid tumors that had stopped responding to other treatments. It specifically enrolled patients whose tumors had certain genetic changes in the …

Matched conditions: B-RAF MUTATION-RELATED TUMORS

Phase: PHASE1 • Sponsor: MapKure, LLC • Aim: Disease control

Last updated Feb 27, 2026 15:19 UTC

B-RAF MUTATION-RELATED TUMORS

Get alerted when new B-RAF MUTATION-RELATED TUMORS trials appear

First human test of new cancer drug halted early